Drug-Resistant Gram-Positive Cocci as Etiological Factors of Cardiac Implantable Electronic Device Infections—Data from the EXTRACT Registry
Antibiotics · 27.03.2026 · 15 (4) · 345
DOI: 10.3390/antibiotics15040345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 27.03.2026. Verfasst von Danuta Łoboda und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrocardiology and Heart Failure, Medical University of Silesia, 40-635 Katowice, Poland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia in Katowice and the Medical Research Agency as part of the National Recovery and Resilience Plan, The National Recovery and Resilience Plan.
Abstract (Originalsprache)
Introduction
Bacterial multidrug resistance (MDR) drives treatment with expensive, toxic, or pharmacokinetically suboptimal antibiotics.
Objectives
To assess the prevalence of MDR Gram-positive cocci among isolates from cardiac implantable electronic device (CIED) infections at a Polish reference center.
Methods
Data come from the “EXTRACT” registry (ClinicalTrials.gov ID NCT05775783), which covers 702 transvenous lead extraction procedures. Blood samples and intraoperative swabs were collected from participants with CIED infection.
Results
From 209 cases with isolated pocket infection (PI) (107, 51.2%) or systemic infections (102, 48.8%), 263 Gram-positive cocci were cultured. They were: coagulase-negative staphylococci (CoNS) (177, 67.3%), Staphylococcus aureus (62, 23.6%), enterococci (15, 5.7%), streptococci (8, 3.0%), and others (1, 0.4%). The highest MDR rate was among CoNS (46.9%). CoNS exhibited methicillin resistance (MR-CoNS) in 55.9% with co-resistance to macrolides (73.2%), lincosamides (51.0%), fluoroquinolones (56.1%), aminoglycosides (41.4%), tetracyclines (29.6%), and co-trimoxazole (29.3%). Resistance to daptomycin (5.3%) and linezolid (2.0%) in MR-CoNS was rare. The frequency of MDR S. aureus was 8.1%. Methicillin resistance in S. aureus (MRSA, 6.5%) co-occurred with resistance to macrolides/lincosamides and fluoroquinolones (100% for both) or linezolid (25.0%). All MDR staphylococci were vancomycin-susceptible. High-level aminoglycoside resistance (HLAR) in Enterococcus faecalis (53.8%) was accompanied by levofloxacin co-resistance (66.7%). Conversely, E. faecium HLAR (50.0%) strains showed 100.0% β-lactam resistance. Vancomycin-resistant enterococci (VRE) accounted for 6.7%; the VRE E. faecium strain was tigecycline- and linezolid-susceptible. Among viridans group streptococci, β-lactam and lincosamides resistance was common (40.0% for both), with 50.0% of co-resistance.
Conclusions
Epidemiological data may improve the effectiveness of empirical antibiotic therapy for CIED-related infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Electrocardiology and Heart Failure, Medical University of Silesia, 40-635 Katowice, Poland.
- Department of Electrocardiology, Upper-Silesian Medical Centre in Katowice, 40-635 Katowice, Poland.
- Doctoral School, Medical University of Silesia, 40-055 Katowice, Poland.
- Department of Microbiology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 41-200 Sosnowiec, Poland.
- Department of Basic Biomedical Science, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 41-200 Sosnowiec, Poland.
ORCID-Profile: Danuta Łoboda, Sylwia Gładysz-Wańha, Michał Joniec, Robert D Wojtyczka, Beata Sarecka-Hujar, Denis Swolana, Sławomir Wilczyński, Krzysztof S Gołba
Förderung
- Medical University of Silesia in Katowice and the Medical Research Agency as part of the National Recovery and Resilience Plan
- The National Recovery and Resilience Plan
Zitieren
APA
Łoboda, D., Gładysz-Wańha, S., Joniec, M., Piłat, E., Wojtyczka, R. D., Sarecka-Hujar, B., Staroń, J., Swolana, D., Gibiński, M., Simionescu, K., Wilczyński, S., & Gołba, K. S. (2026). Drug-Resistant Gram-Positive Cocci as Etiological Factors of Cardiac Implantable Electronic Device Infections—Data from the EXTRACT Registry. Antibiotics, 15(4), 345. https://doi.org/10.3390/antibiotics15040345
Vancouver
Łoboda D, Gładysz-Wańha S, Joniec M, Piłat E, Wojtyczka RD, Sarecka-Hujar B, et al. Drug-Resistant Gram-Positive Cocci as Etiological Factors of Cardiac Implantable Electronic Device Infections—Data from the EXTRACT Registry. Antibiotics. 2026;15(4):345. doi:10.3390/antibiotics15040345
BibTeX
@article{oboda2026,
author = {Łoboda, Danuta and Gładysz-Wańha, Sylwia and Joniec, Michał and Piłat, Eugeniusz and Wojtyczka, Robert D and Sarecka-Hujar, Beata and Staroń, Julia and Swolana, Denis and Gibiński, Michał and Simionescu, Karolina and Wilczyński, Sławomir and Gołba, Krzysztof S},
title = {Drug-Resistant Gram-Positive Cocci as Etiological Factors of Cardiac Implantable Electronic Device Infections—Data from the EXTRACT Registry},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {4},
pages = {345},
doi = {10.3390/antibiotics15040345}
}
EUVIMED